drugset / Trial / NCT02401529

Effect of Steroids on Post-tonsillectomy Morbidities

NCT02401529 ↗

Phase 2 Completed 100 enrolled King Fahd General Hospital
RandomizedParallel-groupDouble-blindSupportive care

Summary

This study aims to evaluate the effect of postoperative systemic rapid onset and short acting dexamethasone followed by a tapering dose of oral prednisolone on post-tonsillectomy morbidities. Half of the patients who comply with the inclusion criteria were selected to receive a single postoperative dose of intravenous dexamethasone followed by oral steroids; the second group received placebo.

Timeline

Start
2013-01
Primary completion
2014-03
Completion
2014-03

Outcome

Met primary endpoint

registry analysis (superiority or other test); IV Dexamethasone and Oral Prednisolone vs Placebo; p = 0.033; Chi-squared NCT02401529 ↗

registry analysis (superiority or other test); IV Dexamethasone and Oral Prednisolone vs Placebo; p = 0.026; Chi-squared NCT02401529 ↗

registry analysis (superiority or other test); IV Dexamethasone and Oral Prednisolone vs Placebo; p = 0.016; Chi-squared NCT02401529 ↗

registry analysis (superiority or other test); IV Dexamethasone and Oral Prednisolone vs Placebo; p = 0.019; Chi-squared NCT02401529 ↗

registry analysis (superiority or other test); IV Dexamethasone and Oral Prednisolone vs Placebo; p = 0.012; Chi-squared NCT02401529 ↗

registry analysis (superiority or other test); IV Dexamethasone and Oral Prednisolone vs Placebo; p = 0.024; Chi-squared NCT02401529 ↗

registry analysis (superiority or other test); IV Dexamethasone and Oral Prednisolone vs Placebo; p = 0.02; Chi-squared NCT02401529 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 0.15 mg/kg Intravenous
Subject Prednisolone Other / unclassified 0.25 mg/kg Oral
Background Acetaminophen Small molecule 15 mg/kg —

Indications

No indication recorded.